Telerx, a leader in U.S. customer care services, today announced that it has completed its acquisition of C3i, a leading provider of technology support services for the life sciences industry. This acquisition will provide Telerx with the global infrastructure to expand its business services outside the United States while maintaining its current domestic operations. The acquisition was completed on June 30, 2014.
C3i serves more than half of the world's largest pharmaceutical companies, delivering 24/7 global, multi-lingual service desk support, end-user training and hardware provisioning services. As a result of the acquisition, Telerx will now deliver services through eight operations centers in the United States, one in Europe and two in Asia.
"As a provider of services and solutions to the pharmaceutical and healthcare industries for more than 30 years, Telerx understands the ever increasing reliance on outside expertise to support a variety of needs, especially in the areas of pharmacovigilance, adherence, patient engagement and support, and access and reimbursement," said Linda Schellenger, president of Telerx. "We are proud to welcome C3i to our company, continue our growth, and most importantly provide our clients with state-of-the-art service in the U.S. and abroad."
Telerx Healthcare ConneXions™ supports a wide variety of healthcare clients, including those in the pharmaceutical, medical device and biotech industries. The company's HIPAA compliant, state-of-the-art contact centers are staffed with nurses, pharmacists, nutritionists and other healthcare specialists, depending on program needs. The company also provides technology to assist clients with processes and existing infrastructure, and to help connect them with patients and providers, enabling quality and outcome improvements.